中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [25]
广州地球化学研究所 [1]
宁波材料技术与工程研... [1]
上海应用物理研究所 [1]
采集方式
OAI收割 [28]
内容类型
期刊论文 [28]
发表日期
2024 [2]
2023 [1]
2021 [1]
2020 [2]
2019 [1]
2017 [1]
更多
学科主题
筛选
浏览/检索结果:
共28条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
期刊论文
OAI收割
MOLECULAR CANCER THERAPEUTICS, 2024, 卷号: 23, 期号: 11, 页码: 1639-1651
作者:
Yue, Hangtian
;
Xu, Hui
;
Ma, Lanping
;
Li, Xiyuan
;
Yang, Biyu
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2024/12/11
Stable Zirconium Isotopic Compositions of the Metasomatized Mantle
期刊论文
OAI收割
JOURNAL OF GEOPHYSICAL RESEARCH-SOLID EARTH, 2024, 卷号: 129, 期号: 2, 页码: 16
作者:
Zou, Zongqi
;
Xu, Yi-Gang
;
Wang, Zaicong
;
Hu, Chuyu
;
Feng, Lanping
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2024/09/12
Zr isotopes
Zr/Hf
high-field strength elements
basalts
metasomatized mantle
mantle metasomatism
Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers
期刊论文
OAI收割
MOLECULAR CANCER THERAPEUTICS, 2023, 卷号: 22, 期号: 8, 页码: 913-925
作者:
Zhou, Wei
;
Fang, Peng
;
Yu, Dongan
;
Ren, Hongyuan
;
You, Meng
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2023/10/17
Carbon Fibers with Low Cost and Uniform Disordered Structure Derived from Lignin/Polyacrylonitrile Composite Precursors
期刊论文
OAI收割
FIBERS AND POLYMERS, 2021, 卷号: 22, 期号: 1, 页码: 240-248
作者:
Song, Le
;
Ouyang, Qin
;
Huang, Xianwen
;
Ma, Hongbo
;
Chen, Peng
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2021/12/01
THERMAL-BEHAVIOR
LIGNIN
SPECTROSCOPY
MANUFACTURE
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function
期刊论文
OAI收割
MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 11, 页码: 2340-2352
作者:
Jin, Rui
;
Liu, Liang
;
Xing, Yun
;
Meng, Tao
;
Ma, Lanping
  |  
收藏
  |  
浏览/下载:69/0
  |  
提交时间:2020/12/24
Facile synthesis of new functionalized 3,4-dihydro-2H-pyrroles using 2-isocyanoacetates
期刊论文
OAI收割
TETRAHEDRON LETTERS, 2020, 卷号: 61, 期号: 23, 页码: 5
作者:
Zhang, Huijie
;
Lv, Kaikai
;
Ma, Lanping
;
Zhang, Yongliang
;
Yu, Ting
  |  
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2020/07/01
3,4-Dihydro-2H-pyrroles
2-Isocyanoacetates
(E)-2-Styrylbenzothiazole
Acrylonitriles
The Structure of MT189-Tubulin Complex Provides Insights into Drug Design
期刊论文
OAI收割
LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 卷号: 16, 期号: 9, 页码: 1069-1073
作者:
Li, Zhongping
;
Ma, Lingling
;
Wu, Chengyong
;
Meng, Tao
;
Ma, Lanping
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2020/07/01
Crystal structure
tubulin
colchicine binding site
inhibitor
MT189
drug design
Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma
期刊论文
OAI收割
ONCOTARGET, 2017, 卷号: 8, 期号: 35, 页码: 59086-59102
作者:
Zhang, Xuesai
;
Li, Qingrou
;
Zhao, Hui
;
Ma, Lanping
;
Meng, Tao
  |  
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2019/01/08
tissue factor
triple negative breast cancer
pancreatic adenocarcinoma
metastasis
antibody-drug conjugate
Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer
期刊论文
OAI收割
ONCOTARGET, 2016, 卷号: 7, 期号: 41, 页码: 67071-67086
作者:
Qian, Jianchang
;
Chen, Yaqing
;
Meng, Tao
;
Ma, Lanping
;
Meng, Lanfang
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2019/01/08
mTOR kinase inhibitor
mTORC2
apoptosis
lipid metabolism
Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2016, 卷号: 6, 期号: 1, 页码: 93-99
作者:
Chen, Danqi
;
Shen, Aijun
;
Fang, Guanghua
;
Liu, Hongchun
;
Zhang, Minmin
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/01/08
Histone deacetylases inhibitor
Anticancer
Tetrahydroisoquinoline
Structure-activity relationship